ANY LAB TEST NOW(R) Announces Partnership with EVIO, Inc. (OTC: EVIO) to Provide Hemp Oil and Hemp Derived CBD Product Testing
Rhea-AI Summary
ANY LAB TEST NOW has partnered with EVIO (OTC PINK:EVIO) to provide testing for hemp oil and CBD products. This collaboration introduces the ISO-17025 accredited CBD Safety Panel, allowing manufacturers and retailers to ensure product safety and transparency. The panel includes tests for cannabinoid profiles, pesticides, heavy metals, and more. With over 180 locations across the US, this partnership aims to enhance consumer safety in the growing CBD market.
Positive
- Partnership with ANY LAB TEST NOW enhances EVIO's market reach with over 180 testing locations.
- Introduction of ISO-17025 accredited CBD Safety Panel provides comprehensive testing services.
- Potential to strengthen consumer confidence in CBD product safety and transparency.
Negative
- None.
News Market Reaction – EVIO
In the trading session that priced this news, EVIO declined 7.69%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HENDERSON, NV / ACCESSWIRE / November 19, 2020 / ANY LAB TEST NOW®, a leading provider of direct access lab testing established a partnership with EVIO (OTC PINK:EVIO), an ISO accredited testing company to enable CBD manufacturers and retailers to test CBD Products for safety and transparency.
ANY LAB TEST NOW® announced that it will now provide hemp oil and hemp derived CBD product testing for product manufacturers, retailers and consumers. ANY LAB TEST NOW® with over 180 walk-in locations across the US, will now offer the EVIO LABS ISO-17025 accredited CBD Safety Panel which includes the following tests: Cannabinoid Profile, Pesticides, Heavy Metals, Microbial Impurities Mycotoxins, and Moisture Content. In addition, ANY LAB TEST NOW® customers can also test the actual products they use for Residual Solvents like butane and propane, a full list of cannabinoids, and, Vitamin E Acetate a substance linked to EVALI illnesses.
According to Sandra Andrews, Toxicology Specialist at ANY LAB TEST NOW®, "With the recent trend of consumers purchasing more hemp oil and hemp derived CBD products, we see this ISO-17025 accredited testing solution as an opportunity to provide a needed service for our customers.
"EVIO LABS is honored to be selected by ANY LAB TEST NOW® as their exclusive HEMP and CBD testing partner," stated EVIO Labs CEO, William Waldrop "our mission is consumer safety and with so many new CBD products coming on line, having a partner with over 180 locations will provide CBD manufacturers, distributors and retailers local access to our testing platform."
About ANY LAB TEST NOW®
Founded in 1992, ANY LAB TEST NOW is a franchise direct access lab testing company that provides thousands of standard lab tests to consumers and businesses in a professional, convenient and cost-effective, transparent manner. With more than 180 facilities around the U.S., ANY LAB TEST NOW offers a variety of affordable and confidential lab tests to consumers and businesses including general health and wellness panels, pregnancy, HIV/STD, drug, paternity and many more tests. To learn more about ANY LAB TEST NOW, visit www.anylabtestnow.com or like us on Facebook, www.facebook.com/anylabtestnowcorp.
About EVIO Inc.
EVIO Labs is a provider of cannabis, hemp, and CBD testing. EVIO maintains licensed and accredited cannabis, CBD, and hemp full-service testing laboratory operations, and provides clients with quality analytical, R&D, and consulting services to produce the best, compliant products. EVIO provides quality assurance to consumers that the potency listed on the label matches what is in the package, and that the product is free of harmful contaminants.
For more information, visit www.eviolabs.com.
Safe Harbor Statement
Any statements in this press release that are not statements of historical fact may be considered forward-looking statements pertaining to anticipated or projected plans, performance, and developments, as well as other statements relating to future operations and results. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only, and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, the Company's ability to complete product testing and launch product commercially, the acceptance of product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in Company reports filed with the Securities and Exchange Commission, available at www.sec.gov or www.eviolabs.com.
For Further Information:
William Waldrop, CEO
investorrelations@eviolabs.com
702-748-9944
SOURCE: EVIO, Inc.
View source version on accesswire.com:
https://www.accesswire.com/617576/ANY-LAB-TEST-NOWR-Announces-Partnership-with-EVIO-Inc-OTC-EVIO-to-Provide-Hemp-Oil-and-Hemp-Derived-CBD-Product-Testing